Navigation Links
inVentiv Clinical Expands Operations to Emerging Latin American Region
Date:3/13/2008

olutions provides clinical trial management and monitoring, data management and biostatistics solutions, medical writing, regulatory consulting and liaison services and patient and investigator recruitment. These services are complemented by traditional clinical staffing capabilities through our industry leading staffing divisions, MedFocus and Smith Hanley Consulting Group. For more information, visit http://www.inventivclinical.com.

About inVentiv Health

inVentiv Health, Inc. (Nasdaq: VTIV) is an insights-driven global healthcare leader that provides dynamic solutions to deliver customer and patient success. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial, and inVentiv Patient Outcomes. inVentiv Health's client roster is comprised of more than 325 leading pharmaceutical, biotech, life sciences and healthcare payor companies, including all top 20 global pharmaceutical manufacturers. For more information, visit http://www.inventivhealth.com.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts;
'/>"/>

SOURCE inVentiv Health, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. inVentiv Health to Present at the 20th Annual Bear Stearns Healthcare Conference
2. inVentiv Health to Announce Third Quarter Results and Conduct Conference Call on Wednesday, November 7, 2007
3. inVentiv Health Launches Fourth Business Segment: inVentiv Patient Outcomes
4. inVentiv Health to Present at the 2007 Credit Suisse Healthcare Conference
5. inVentiv Health Creates Client Development and Integration Team
6. inVentiv Health Provides Updated Information on December 11th Investor Day
7. inVentiv Health to Announce Fourth Quarter and Full Year 2007 Results and Conduct Conference Call on Thursday, February 28th
8. inVentiv Health Ranked #17 by Training Magazine in its 2008 List of Top 125 Training Companies
9. inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007
10. inVentiv Selling Solutions Selected to Provide Sales Team for Cephalon Inc.
11. Radiologists encouraged to look beyond cancer for clinically unseen diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...k of Peers, Parents and Professionals Shares Exper...n, Employment, Recreation, More , , WASHING...a leading international disability association wor... people with significant disabilities announces th...eer resource directory accessible to people with d...
(Date:12/2/2008)...melteon show it could aid shift workers, people af...ealthDay News) -- The experimental drug tasimelteo... or night shifts, according to the results of two ...ded 39 people randomly assigned to receive either ...on, or a placebo. They were monitored for seven ni...
(Date:12/2/2008)... Dec. 2 MEDai, Inc., headquartered...rovider, has added a new module,to its existing s...and-alone,module monitors a population,s complian...ts stakeholders when there has been a deviation fr... Guidelines(TM) provides,real-time decision suppo...
(Date:12/2/2008)...s Nearly Half Have Skipped Medical Care Due to Cos...swire-USNewswire/ -- A new survey released today b...RC) highlights another troubling aspect of the cur...eek health care for themselves or their families t...men say their health has gotten worse over the pas...
Breaking Medicine News(10 mins):Health News:New Website Links People With Disabilities to Peers for Help 2Health News:Drug Effective for Temporary Sleep Disruptions 2Health News:MEDai Evidence-Based Guideline Reporting Provides Decision Support at Point of Care 2Health News:Rising Health Costs Prompt Women to Neglect Health 2Health News:Rising Health Costs Prompt Women to Neglect Health 3Health News:Rising Health Costs Prompt Women to Neglect Health 4
...sia is catching up fast with the West. Yes, but no...tunately in cancer incidence too. Smoking, drink...ous cancers will combine with larger populations ...ous diseases to drive Asian cancer rates up 60 per...
...wo Philippines examiners were charged with corrupt...mination, officials said, in a scandal that cast ...are the first two people to be charged in connecti... commission issuing a temporary ban on the 17,000 ...
...owerful Shiite politician Abdel Aziz al-Hakim retu...receiving treatment for cancer in Tehran. Hakim, ...e parliament, spent nearly two weeks abroad in a t...cal tests in the United States and treatment in Ir...
...mputees can now breathe a sigh of relief for resea...y (MIT) in Boston have developed two robotic devic...ural, energy-efficient gaits. Dr. Hugh Herr, Assi...Biomechatronics Group at the institute, has been q...
Other Medicine News:Health News:Surge in Cancer Incidence in Asia Feared 2Health News:Surge in Cancer Incidence in Asia Feared 3Health News:Top Iraqi Shiite Leader Returns Home 2Health News:Now, Natural Looking, Energy Efficient Robotic Ankles for Amputees 2
(Date:12/2/2008)...re-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ),...prietary antibodies for the treatment of cancer, i...ed that it has entered into an agreement expanding...th Kingsbridge Capital Limited, a private investme...bridge has committed to provide up to $75 million ...
(Date:12/1/2008)...-- TargeGen has announced that an oral,presentati...-based clinical,trial of TG101348 in myeloprolife... 2008 American Society of Hematology (ASH) Meeting...llows:, Title: A Phase I Study ... JAK2-Selective Inhibitor, in Patients w...
(Date:12/1/2008)...gene is a two-way switch that, if turned off, caus...so that they lose their identity and become more l...nn., Dec. 1 Scientists...covered that a certain differentiated cell type is...the constant expression of a gene called Prox1 t...
(Date:12/1/2008)...r Tuesday, December 9 at 11:00 am ET to Discuss Ph...N FRANCISCO, Calif., Dec. 1 /PRNewswire-FirstCal...S ), a biopharmaceutical company focused on the de...erapeutics, today announced new data from its stud...ill be presented during the 50th American Society ...
Breaking Medicine Technology:Micromet Expands Committed Equity Financing Facility to $75 Million 2Micromet Expands Committed Equity Financing Facility to $75 Million 3Micromet Expands Committed Equity Financing Facility to $75 Million 4Micromet Expands Committed Equity Financing Facility to $75 Million 5Micromet Expands Committed Equity Financing Facility to $75 Million 6Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3NO on Prop 8 Campaign Slams Dishonest Mailer Targeting African American Voters 28477 1NO on Prop 8 Campaign Slams Dishonest Mailer Targeting African American Voters 28477 2Easy Ethnic Election 28475 1Easy Ethnic Election 28475 2FDA Faulted for Stance on Chemical in Plastics 28471 1FDA Faulted for Stance on Chemical in Plastics 28471 23SBio Inc Announces Preliminary Third Quarter 2008 Results 8793 13SBio Inc Announces Preliminary Third Quarter 2008 Results 8793 23SBio Inc Announces Preliminary Third Quarter 2008 Results 8793 33SBio Inc Announces Preliminary Third Quarter 2008 Results 8793 43SBio Inc Announces Preliminary Third Quarter 2008 Results 8793 53SBio Inc Announces Preliminary Third Quarter 2008 Results 8793 6
...is, often conducted in a physicians office practic...array of ailments; UTIs, diabetes, several cancers...iseases. The estimated global market for urinalys...r and is growing strongly. For such a fundamental,...rocedure, the manufacturers of urinalysis analyzer...
...cois Rossi Medical Hematology and Oncology CHU Lap...RP) is an acute-phase protein that has long been r...P measurement can complement a range of diagnostic.... However, as economic rationalization becomes a ... apparent that such areas of frequent laboratory t...
Other Medicine Technology:Urinalysis Analyzers: Large Capabilities in Every Size Device 2Urinalysis Analyzers: Large Capabilities in Every Size Device 3Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing 2Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing 3Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing 4
...sively for the airlines industry:, ,AirSeps A...ured for the airlines to assist their supplemental...everal overseas airlines. With the US governments ...on specific Boeing commercial aircraft, AirSep set...
...p's LifeStyle Portable Oxygen Concentrator is the ...nywhere. At less than 10 lbs (4.5 kg), this unit w... and highly active oxygen patient., ,Operatin...logies of both an oxygen concentrator and an oxyge...
...ers up to 10 LPM of oxygen reducing the delivery c...ts. The M10 is engineered to reduce the cost of pr...parts than any other concentrator on the market. F...p you to reduce expenditure on accessories and unn...
The Hudson RCI oxygen conserving cannula incorporates a patented "split prong" nose design and two oxygen supply tubes with standard connectors. This design provides the utmost control and comfort in
Medicine Products: